Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial
Daniel Vincent O'Hara, Abhinav Bassi, Arlen Wilcox, Vivekanand Jha, Vinay Rathore, Sanjay D'Cruz, Thomas L Snelling, Mark Jones, James Totterdell, Ashpak Bangi, Manish Kumar Jain, Carol Pollock, Louise Burrell, Gregory Fox, Cheryl Jones, Sradha Kotwal, Sharifah Faridah Syed Omar, Meg Jardine
BMJ Open Oct 2024, 14 (10) e081790; DOI: 10.1136/bmjopen-2023-081790